Octreotide Injection 50 MCG, 100 MCG, 200 MCG

Octreotide Injection 50 MCG, 100 MCG, 200 MCG - Image 2

Categories:Hormonal Therapy Product, Somatostatin Analogue

Octreotide Injection 50 MCG, 100 MCG, 200 MCG

Download as PDF

Enquire Now

Add to Compare

Description
Reviews (0)

Description

PRODUCT DESCRIPTION:

Octreotide is a synthetic somatostatin analogue with potent inhibitory effects on a wide range of endocrine and exocrine functions.

It is used for the management of acromegaly, neuroendocrine tumors, and severe diarrhea and flushing associated with carcinoid syndrome and VIPomas.

Available in 50 MCG, 100 MCG, and 200 MCG strengths, Octreotide Injection offers rapid onset and is ideal for both acute and maintenance settings.

Manufactured under GMP-compliant standards, it ensures high purity, consistent bioavailability, and global regulatory readiness.

Formulation & Presentation:

Dosage Form: Injectable Solution
Presentation: Sterile, single-use ampoule or vial (customizable as per market demand)
Available Strengths: 50 MCG, 100 MCG, 200 MCG
Route of Administration: Intramuscular (IM), subcutaneous (SC), or intravenous (IV) injection or as per clinical indication and severity (As per physician’s discretion or decision)

Therapeutic Indications:

Management of acromegaly when surgery or radiotherapy is ineffective or contraindicated
Treatment of severe diarrhea and flushing episodes in patients with functional gastroenteropancreatic neuroendocrine tumors
Symptomatic control of carcinoid tumors, VIPomas, and glucagonomas
Control of gastrointestinal fistulas and in postoperative pancreatic surgery (off-label in select cases)

Side Effects:

COMMON:
- Injection site pain or irritation
- Abdominal cramps, nausea
- Flatulence or bloating
- Gallstone formation with long-term use
SERIOUS (RARE):
- Bradycardia or cardiac arrhythmias
- Hyperglycemia or hypoglycemia
- Hepatic dysfunction
- Hypothyroidism
PRECAUTIONS:
- Monitor blood glucose regularly during therapy
- Periodic ultrasound monitoring of the gallbladder is advised for long-term treatment
- Use cautiously in patients with cardiac disorders, thyroid dysfunction, or hepatic impairment
- Dose adjustment may be required in elderly or renally impaired patients

Reviews

There are no reviews yet.

Be the first to review “Octreotide Injection 50 MCG, 100 MCG, 200 MCG” Cancel reply

TECHNICAL INFORMATION

Product Specifications:

HSN Code: To be assigned per international classification standards & import jurisdiction
Weight: Approx. 40g per Carton (With Packaging)
Dimensions: (15x1x8 CMS)
Shelf Life (Subject To Country Specific Guidelines): 2 to 3 years under recommended storage conditions from date of manufacture or as per label specifications. Cold chain recommended.
Storage: Oil-based injectable solution requiring cold-chain logistics (if specified by packaging). Protect from moisture and direct sunlight. The solution should be used strictly as per label guidelines.

Regulatory Status & Supply Information:

Regulatory Status: WHO-GMP Complaint Manufacturing. Further certifications available on request
Exports Ready Dossiers: Dossier Available (CTD/eCTD formats)
Stability: Compliant
MOQ: Negotiable. Based on market & registration status
Export Options: Available for private label, institutional supply, or branded export

Who Should Source This Product?

Octreotide Injection is essential for oncology centers, endocrinology units, gastroenterology clinics, tertiary care hospitals, and specialized institutions treating neuroendocrine disorders.
It is particularly relevant for public health tenders, NGOs, and importers across Africa, Southeast Asia, Latin America, and Eastern Europe, where access to advanced hormonal therapies is expanding.

Why Source from PHARMET?